Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
79 | Cancer Drug Discovery and Development | book series | 8 | 18 | 0 | 2391 | 0 | 0 | 0.00 | 132.83 | 43.14 | ||
78 | Cancer Immunity | journal | 1.564 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
77 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.901 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
76 | Hormones and Cancer | journal | 1.420 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
75 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 19 | 601 | 0 | 19 | 0.00 | 150.25 | 36.62 | ||
74 | Oncoscience (discontinued) | journal | 34 | 107 | 0 | 4873 | 0 | 0 | 0.00 | 45.54 | 40.83 | ||
73 | Report on carcinogens. Monograph on .. | book series | 0.111 | 2 | 2 | 2 | 687 | 0 | 2 | 0.00 | 343.50 | 52.00 | |
72 | Annals of Cancer Research and Therapy | journal | 0.126 Q4 | 7 | 3 | 28 | 62 | 5 | 28 | 0.11 | 20.67 | 5.88 | |
71 | Cancer Therapy | journal | 0.221 Q4 | 9 | 4 | 14 | 408 | 19 | 14 | 0.18 | 102.00 | 30.00 | |
70 | Current Cancer Research | book series | 0.162 Q4 | 8 | 17 | 65 | 1582 | 20 | 62 | 0.24 | 93.06 | 30.30 | |
69 | Current Problems in Cancer | journal | 0.297 Q4 | 47 | 19 | 83 | 1457 | 50 | 64 | 0.49 | 76.68 | 53.85 | |
68 | Journal of Cancer Science and Therapy (discontinued) | journal | 0.255 Q4 | 22 | 43 | 233 | 1525 | 130 | 202 | 0.62 | 35.47 | 43.02 | |
67 | Oncology | journal | 0.430 Q4 | 83 | 189 | 790 | 3264 | 479 | 535 | 0.62 | 17.27 | 37.12 | |
66 | National Toxicology Program technical report series | journal | 0.211 | 22 | 0 | 19 | 0 | 25 | 19 | 1.55 | 0.00 | 0.00 | |
65 | Oncology Research | journal | 0.613 Q3 | 76 | 30 | 136 | 1033 | 242 | 136 | 1.63 | 34.43 | 34.38 | |
64 | Journal of Experimental Therapeutics and Oncology | journal | 0.489 Q3 | 40 | 13 | 68 | 354 | 100 | 65 | 1.68 | 27.23 | 27.66 | |
63 | Technology in Cancer Research and Treatment | journal | 0.613 Q3 | 72 | 76 | 186 | 2657 | 394 | 181 | 1.82 | 34.96 | 39.58 | |
62 | Sub-Cellular Biochemistry | journal | 1.032 Q3 | 81 | 121 | 219 | 11484 | 391 | 213 | 1.84 | 94.91 | 38.89 | |
61 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.820 Q3 | 65 | 148 | 350 | 4852 | 697 | 340 | 1.90 | 32.78 | 40.39 | |
60 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.638 Q3 | 68 | 64 | 277 | 1853 | 563 | 273 | 2.03 | 28.95 | 37.61 | |
59 | Anti-Cancer Drugs | journal | 0.744 Q3 | 102 | 148 | 397 | 5845 | 859 | 388 | 2.06 | 39.49 | 37.30 | |
58 | Journal of the National Cancer Institute. Monographs | journal | 1.176 Q2 | 95 | 40 | 103 | 1456 | 271 | 95 | 2.43 | 36.40 | 55.56 | |
57 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 1.031 Q3 | 90 | 92 | 344 | 2935 | 865 | 331 | 2.48 | 31.90 | 32.04 | |
56 | Melanoma Research | journal | 1.032 Q3 | 80 | 100 | 214 | 3166 | 512 | 203 | 2.48 | 31.66 | 46.28 | |
55 | Clinical Breast Cancer | journal | 1.163 Q2 | 80 | 85 | 208 | 2733 | 611 | 200 | 2.52 | 32.15 | 43.76 | |
54 | Experimental Hematology | journal | 1.388 Q2 | 129 | 109 | 329 | 5471 | 883 | 310 | 2.54 | 50.19 | 40.14 | |
53 | Nutrition and Cancer | journal | 0.926 Q3 | 130 | 153 | 462 | 6035 | 1248 | 434 | 2.57 | 39.44 | 45.29 | |
52 | Cancer Investigation | journal | 1.013 Q3 | 93 | 66 | 265 | 3040 | 685 | 263 | 2.61 | 46.06 | 42.86 | |
51 | Recent Results in Cancer Research | book series | 1.082 Q2 | 63 | 83 | 197 | 4493 | 561 | 192 | 2.69 | 54.13 | 35.33 | |
50 | Current Pathobiology Reports | journal | 33 | 29 | 33 | 2202 | 89 | 33 | 2.70 | 75.93 | 34.09 | ||
49 | Nuclear Medicine and Biology | journal | 0.946 Q3 | 98 | 128 | 433 | 4141 | 1220 | 420 | 2.75 | 32.35 | 31.76 | |
48 | Breast | journal | 1.130 | 98 | 134 | 552 | 4970 | 1540 | 517 | 2.82 | 37.09 | 46.76 | |
47 | Medical Oncology | journal | 1.006 Q3 | 90 | 541 | 1334 | 16340 | 3746 | 1295 | 2.91 | 30.20 | 38.72 | |
46 | Current Hematologic Malignancy Reports | journal | 1.110 Q2 | 44 | 51 | 120 | 3381 | 320 | 118 | 2.92 | 66.29 | 40.80 | |
45 | Cancer genetics | journal | 1.399 Q2 | 52 | 80 | 248 | 2346 | 722 | 236 | 2.93 | 29.33 | 44.49 | |
44 | Molecular Imaging and Biology | journal | 1.057 Q2 | 78 | 97 | 324 | 3216 | 1051 | 313 | 3.04 | 33.15 | 31.30 | |
43 | European Journal of Cancer Prevention | journal | 1.219 Q2 | 88 | 86 | 263 | 3405 | 746 | 245 | 3.10 | 39.59 | 49.17 | |
42 | Cancer Biology and Therapy | journal | 1.688 Q2 | 130 | 193 | 584 | 7556 | 2160 | 523 | 3.24 | 39.15 | 40.37 | |
41 | Cancer cytopathology | journal | 1.150 Q2 | 68 | 137 | 237 | 3381 | 824 | 187 | 3.37 | 24.68 | 46.24 | |
40 | Nitric Oxide - Biology and Chemistry | journal | 1.038 Q2 | 110 | 94 | 241 | 5917 | 856 | 228 | 3.37 | 62.95 | 40.22 | |
39 | Cytotherapy | journal | 1.193 Q2 | 105 | 178 | 429 | 7429 | 1477 | 392 | 3.50 | 41.74 | 42.54 | |
38 | Stem Cell Reviews and Reports | journal | 1.564 Q2 | 87 | 69 | 277 | 4816 | 1198 | 272 | 3.52 | 69.80 | 45.87 | |
37 | Translational Oncology | journal | 1.358 Q2 | 72 | 95 | 190 | 3620 | 656 | 190 | 3.53 | 38.11 | 39.91 | |
36 | Clinical Lung Cancer | journal | 1.254 Q2 | 74 | 70 | 225 | 2212 | 766 | 219 | 3.58 | 31.60 | 27.99 | |
35 | Tumor Biology | journal | 1.105 Q2 | 101 | 1498 | 869 | 53533 | 3087 | 862 | 3.63 | 35.74 | 38.69 | |
34 | Critical Reviews in Oncogenesis | journal | 2.382 Q1 | 57 | 39 | 92 | 3086 | 366 | 80 | 3.66 | 79.13 | 37.50 | |
33 | Genes and Cancer | journal | 2.971 Q1 | 81 | 36 | 229 | 1597 | 1245 | 218 | 3.78 | 44.36 | 38.50 | |
32 | American Journal of Translational Research (discontinued) | journal | 1.499 Q2 | 80 | 79 | 141 | 3067 | 553 | 141 | 3.80 | 38.82 | 41.47 | |
31 | Cancer Immunology Research | journal | 2.131 Q1 | 134 | 132 | 88 | 1446 | 331 | 86 | 3.88 | 10.95 | 40.62 | |
30 | Cancer Science | journal | 1.742 Q2 | 166 | 206 | 849 | 7166 | 3532 | 846 | 3.98 | 34.79 | 23.65 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®